Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CFRGYN AS
AS
Active
Org 925756865
Furulunden 20, 5210 Os
General medical practice activities · NACE 8621
Est. 2020
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 5M
+70% vs 2024
EBITDA margin
25.1%
+47% vs 2024
Equity ratio
81.7%
Financial strength
Net profit 2025
NOK 731K
+34% vs 2024
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
1M
0%
2023
1M
0%
2024
1M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 5M
+70%
EBITDA
NOK 1,3M
+47%
Net profit
NOK 731K
+34%
Total assets
NOK 4,4M
+30%
Equity
NOK 3,6M
+26%
Employees
0
—
Company information
Legal name
CFRGYN AS
Org number
925756865
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
7. oktober 2020
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Legevirksomhet og annen naturlig tilknyttet virksomhet.
Contact
Address
Furulunden 20, 5210 Os
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Bjørnafjorden
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
1M
2021
1M
2022
1M
2023
3M
2024
5M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 220
1 397
1 466
2 963
5 039
Staff expenses
−11
−0
−0
−1 061
−2 548
EBITDA
619
973
926
861
1 266
Depreciation & amort.
−64
−64
−71
−201
−330
EBIT
555
909
855
660
936
Net financials
−0
0
−0
38
2
Profit before tax
555
909
855
698
938
Tax
123
200
188
154
207
Net profit
432
709
666
545
731
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 208
1 870
2 561
3 384
4 382
Equity
1 050
1 640
2 306
2 851
3 582
Long-term debt
9
16
17
85
104
Short-term debt
141
214
238
448
697
Total debt
150
230
255
533
801
Financial ratios
5-year trend
EBITDA margin
25.1%
This company
15.8%
Market median
+59% vs market
2021
2025
Equity ratio
81.7%
This company
38.2%
Market median
+114% vs market
2021
2025
Return on equity
20.4%
This company
18.4%
Market median
+11% vs market
2021
2025
Net profit margin
14.5%
This company
8.1%
Market median
+79% vs market
2021
2025
Asset turnover
1.15×
This company
1.12×
Market median
+3% vs market
2021
2025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CF
Christopher Finne Riley
Chief Executive Officer
Chief Executive Officer
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
KS
Kjersti Solberg Eikrem
Chairman
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CFRGYN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Christopher Finne Riley
Chief Executive Officer
0 companies
Kjersti Solberg Eikrem
Chairman
0 companies